Skip to main content
logo
Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
5.82
+0.13 (2.28%)
At close: Apr 2, 2026, 4:00 PM EDT
5.93
+0.11 (1.89%)
After-hours: Apr 2, 2026, 6:58 PM EDT

Precision BioSciences Revenue

In the year 2025, Precision BioSciences had annual revenue of $34.26M, down -50.12%. Precision BioSciences had revenue of $34.20M in the quarter ending December 31, 2025, with 5,261.13% growth.

Revenue (ttm)
$34.26M
Revenue Growth
-50.12%
P/S Ratio
4.38
Revenue / Employee
$503,882
Employees
68
Market Cap
150.17M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202534.26M-34.43M-50.12%
Dec 31, 202468.70M19.97M40.98%
Dec 31, 202348.73M23.63M94.15%
Dec 31, 202225.10M-90.43M-78.28%
Dec 31, 2021115.53M91.24M375.72%
Dec 31, 202024.29M2.05M9.20%
Dec 31, 201922.24M11.36M104.34%
Dec 31, 201810.88M4.40M67.84%
Dec 31, 20176.48M-531.00K-7.57%
Dec 31, 20167.02M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Heron Therapeutics154.90M
Spero Therapeutics66.80M
Fate Therapeutics6.65M
Cibus3.64M
Humacyte2.04M
Oramed Pharmaceuticals2.00M
Molecular Partners AG856.30K
NeOnc Technologies Holdings39.99K
Revenue Rankings

DTIL News

More News